A cheaper, safer CBD alternative? Scientists discover new synthetic CBD analogue alleviates seizures in rats

Findings of the study are the basis of a new start-up, Syncanica, which is developing commercial applications of the new H2CBD compound

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Ingredient manufacturer Kemin Industries is investing in US-based hemp producer Driftless Extracts and has entered into a hemp-based product supply agreement.

FormattedPicture

NUTRITION & HEALTH NEWS

CBD extraction retailer Extract Labs is unveiling an Immune Support CBGa (cannabigerolic acid) CBDa (cannabidiolic acid) tincture. The US-based company says these... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, DSM created a new integrated Food & Beverage group to align more closely with emerging customer and market needs. The F&B platform... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

A new Gencor study is touting its Levagen+ product, which contains palmitoylethanolamide (PEA), is a viable alternative to cannabidiol (CBD) – offering the same... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Australia-based Elixinol Wellness will be bringing its cannabidiol (CBD) supplements and cosmetics to the UK after partnering with British Cannabis. The move comes after... Read More

trans